MedPath
NMPA Approval

Piperazine Phosphate Tablets

国药准字H61021460

January 15, 2021

Drug Information

磷酸哌嗪片

片剂

0.2g

化学药品

January 15, 2021

Company Information

Applicant Company

Manufacturing Company

陕西省咸阳市秦都区平安路8号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

磷酸哌嗪片 - NMPA 批准文号 | MedPath